Format

Send to

Choose Destination
Gynecol Oncol Rep. 2016 Aug 2;17:93-5. doi: 10.1016/j.gore.2016.08.001. eCollection 2016 Aug.

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient.

Author information

1
University of Miami, Miller School of Medicine, United States.
2
Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Miami, United States.
3
Department of Genetics, University of Miami, United States.
4
University of Miami, Miller School of Medicine, United States; Department of Pathology, Jackson Memorial Hospital, United States.
5
University of Miami, Miller School of Medicine, United States; Department of Obstetrics and Gynecology, Division of Gynecology Oncology, University of Miami, United States; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, United States.

Abstract

•First reported case of PPC after BSO in a BRCA1/2-negative, PALB2-positive patient•The PALB2 mutation and genetic counseling is discussed•Multi-gene panel testing can benefit prognostic factors and targeted therapy.

KEYWORDS:

BRIP1; Low-grade serous carcinoma; PALB2; Primary Peritoneal Carcinoma

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center